Primary melanocytic tumor of central nervous system

Primary melanocytic tumors of the central nervous system (CNS) are a rare group of neoplasms that arise from leptomeningeal melanocytes, which are pigment-producing cells normally found in the membranes (meninges) covering the brain and spinal cord. These tumors are distinct from melanoma that has metastasized (spread) to the brain from the skin or other organs. The spectrum of primary CNS melanocytic tumors ranges from benign melanocytomas to intermediate-grade melanocytic tumors to aggressive primary CNS melanomas. They can occur anywhere along the leptomeninges but are most commonly found in the posterior fossa, spinal cord, and base of the skull. Symptoms depend on the tumor's location and size and may include headaches, seizures, focal neurological deficits (such as weakness, numbness, or vision changes), hydrocephalus (buildup of fluid in the brain), spinal cord compression, and signs of increased intracranial pressure. Diffuse forms, such as those seen in neurocutaneous melanocytosis (a related condition involving congenital melanocytic nevi and leptomeningeal melanocytic proliferation), may present with more widespread neurological symptoms. Diagnosis typically involves magnetic resonance imaging (MRI), which often shows characteristic hyperintensity on T1-weighted images due to the paramagnetic properties of melanin, along with histopathological examination of tissue obtained through biopsy or surgical resection. Treatment primarily consists of surgical resection when feasible. For melanocytomas, complete surgical removal may be curative. For primary CNS melanomas or incompletely resected tumors, adjuvant radiotherapy is often considered. The role of systemic therapies, including immunotherapy (such as checkpoint inhibitors) and targeted therapy (for tumors harboring BRAF or NRAS mutations), is being explored but remains limited by the rarity of the condition. Prognosis varies significantly depending on the tumor grade, with melanocytomas generally having a favorable outcome and primary CNS melanomas carrying a poor prognosis.

Common questions about Primary melanocytic tumor of central nervous system